Are you Dr. Lestingi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 72 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1700 Luther LN
Park Ridge, IL 60068Phone+1 847-268-8200Fax+1 847-410-0051
Summary
- Dr. Timothy Lestingi, MD is an oncologist in Park Ridge, Illinois. He is currently licensed to practice medicine in Illinois. He is affiliated with Advocate Lutheran General Hospital, Loyola University Medical Center, and Advocate Illinois Masonic Medical Center.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1991 - 1994
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1988 - 1991
- Ohio State University College of MedicineClass of 1988
Certifications & Licensure
- IL State Medical License 1988 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Most Compassionate Doctor American Registry
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 144 citationsPharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.Elora Gupta, Rosemarie Mick, Jacqueline Ramírez, Xiaolin Wang, Timothy M. Lestingi
Journal of Clinical Oncology. 1997-04-01 - 13 citationsRole of Sorafenib in Overcoming Resistance of Chemotherapy-Failure Castration-Resistant Prostate CancerAndrew Meyer, Peter Cygan, Kathy Tolzien, Angel G. Galvez, Jacob D. Bitran
Clinical Genitourinary Cancer. 2014-04-01 - 402 citationsMetabolic Fate of Irinotecan in Humans: Correlation of Glucuronidation with DiarrheaElora Gupta, Timothy M. Lestingi, Rosemarie Mick, Jacqueline Ramírez, Everett E. Vokes
Cancer Research. 1994-07-15